The gut is the major interface to the outside world. It is our first line of defense as well as where our first exposure happens. It is where we decide if we are immune tolerant of the world or inflamed by the world. Recent research by Dr. Fassano demonstrates that the inflammatory contribution from the gut results in a host of systemic conditions, from neurologic to auto-immune but even contributing to diabetes and some cancers. He also affirms that movement away from a disease centered paradigm is possible by recognizing underlying processes that are occurring before pathology is evident. The gut is our window to prevention and remission. By addressing the triggers of histamine, pathogens and food sensitivities, as well as the body’s ability to handle the assault, through enzymes such as diamine oxidase that degrade histamine, we can halt inflammation and truly practice healthcare and promote wellness. This will further the practitioner’s knowledge and practice as the knowledge of biomarkers and treatment and their meaning in clinical practice. Oral immunoglobulin therapy, strains of probiotics and other innovative therapies are specific for targeting the cause of permeability or alterations in gut based production or enzymes such as diamine oxidase. This lecture will enhance knowledge around the area of gut and its interplay between obesity, diabetes, and neuroendocrine dysfunction further widening our tools for treatment.
- To Understand the extensive influence the gut has on a myriad of pathologies not limited to the GI system.
- We will review the systemic inflammatory pathways that are triggered from gut health
- To understand and be able to actualize the use of biomarkers such as Zonulin, Diamine oxidase, stool culture assessment and food sensitivity assessment as they result to inflammatory process and pathology.
- Review the research and evaluate the strength of the literature as it applies to natural treatments and successful natural modulation of these markers.
- Learn Dr. Burdette’s supplement protocols
Cheryl Burdette, ND, Chief Scientific Advisor, Dunwoody Labs.
Cheryl Burdette, ND, is chief scientific advisor of Dunwoody Labs. She is the educational director and a clinician and runs a residency program for NDs at Progressive Medical, one of the largest integrative clinics in the country. Dr. Burdette serves on IRBs and is an author of the book Laboratory Evaluations of Molecular Medicine. Dr. Burdette lectures extensively nationally and internationally. She graduated from Bastyr University in 2001, and she completed her residency at Cancer Treatment Centers of America. The marriage of her laboratory directorship and clinical practice gives her a unique perspective in functional medicine treatment and testing.